SFX by Ex Libris Inc.

Title:	Structure of an intermediate state in protein folding and aggregation
Source:	Science [0036-8075] Neudecker, P yr:2012

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Stefani, M. "Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution." Journal of molecular medicine 81.11 (2003): 678-699.
description	2.	Abelein, A. "Transient small molecule interactions kinetically modulate amyloid beta peptide self-assembly." FEBS letters 586.22 (2012): 3991-3995.
description	3.	Jahn, Thomas R. "Amyloid formation under physiological conditions proceeds via a native-like folding intermediate." Nature structural & molecular biology 13.3 (2006): 195-201.
description	4.	Faisca, Patricia F. N. N. "Non-native interactions play an effective role in protein folding dynamics." Protein science 19.11 (2010): 2196-2209.
description	5.	Eisenberg, D. "Short protein segments can drive a non-fibrillizing protein into the amyloid state." Protein Engineering, Design & Selection; PEDS 22.8 (2009): 531-536.
description	6.	Selkoe, Dennis J J. "Folding proteins in fatal ways." Nature 426.6968 (2003): 900-904.
description	7.	Dobson, Christopher M M. "Protein folding and misfolding." Nature 426.6968 (2003): 884-890.
description	8.	Selkoe, Dennis J J. "Cell biology of protein misfolding: The examples of Alzheimer's and Parkinson's diseases." Nature cell biology 6.11 (2004): 1054-1061.
description	9.	Dobson, F. "Protein Misfolding, Functional Amyloid, and Human Disease." Annual review of biochemistry 75.1 (2006): 333-366.
description	10.	Netzer, William J. "Chaperones increase association of tau protein with microtubules." Proceedings of the National Academy of Sciences of the United States of America 100.2 (2003): 721-726.
description	11.	Eakin, Catherine M M. "A native to amyloidogenic transition regulated by a backbone trigger." Nature structural & molecular biology 13.3 (2006): 202-8.
description	12.	Myers, Sarah L. "A Systematic Study of the Effect of Physiological Factors on Î²2-Microglobulin Amyloid Formation at Neutral pH." Biochemistry 45.7 (2006): 2311-2321.
description	13.	Alies, B. "The role of metal ions in amyloid formation: General principles from model peptides." Metallomics 5.3 (2013): 183-192.
description	14.	Fawzi, Nicolas L. "Probing exchange kinetics and atomic resolution dynamics in high-molecular-weight complexes using dark-state exchange saturation transfer NMR spectroscopy." Nature protocols 7.8 (2012): 1523-1533.
description	15.	Ghalebani, L. "pH-dependence of the specific binding of Cu(II) and Zn(II) ions to the amyloid-β peptide." Biochemical and biophysical research communications 421.3 (2012): 554-60.
description	16.	Liu, J. "Biased Signaling Pathways in beta(2)-Adrenergic Receptor Characterized by F-19-NMR." Science 335.6072 (2012): 1106-1110.
description	17.	Abelein, A. "Hydrophobicity and Conformational Change as Mechanistic Determinants for Nonspecific Modulators of Amyloid β Self-Assembly." Biochemistry 51.1 (2012): 126-137.
description	18.	Glabe, Charles G G. "Common mechanisms of amyloid oligomer pathogenesis in degenerative disease." Neurobiology of aging 27.4 (2006): 570-575.
description	19.	Radford, Sheena E. "Towards an understanding of the structural molecular mechanism of Î²2-microglobulin amyloid formation in vitro." Biochimica et biophysica acta. Proteins and proteomics 1753.1 (2005): 51-63.
description	20.	Stump, Matthew R. "Mutational Studies Uncover Non-Native Structure in the Dimeric Kinetic Intermediate of the H2A-H2B Heterodimer." Journal of Molecular Biology 401.3 (2010): 518-531.